LAST MINUTE GESCHENK mit Herz und Verstand: Der FLEXINVEST JUNIOR-SPARPLAN. Hier KOSTENLOS abschließen & bis zu 75 € Amazon.de* Gutscheine erhalten!

Novo Nordisk Aktie

NeuKaufen Kaufen Verkaufen Verkaufen

Aktien-Sparplan anlegen Aktien-Sparplan anlegen

81,00 EUR -19,62 EUR -19,50 %

17:45:04

FSE

79,20 EUR -20,10 EUR -20,24 %

17:24:05

GVIE

Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!

JETZT LOSLEGEN

Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handeln Smartphone

Marktkap.439,73 Mrd. EUR

KGV37,40Div. Rendite1,35%

WKNA3EU6F

ISINDK0062498333

SymbolNONOF

Novo Nordisk Aktien News

Sortieren:Datum Meistgelesen

01.09.22GlobeNewswireNovo Nordisk to acquire Forma Therapeutics and expand presence in sickle cell disease and rare blood disorders

22.08.22GlobeNewswireNovo Nordisk successfully completes phase 2 trial with CagriSema in people with type 2 diabetes

03.08.22GlobeNewswireNovo Nordisk's sales increased by 25% in Danish kroner and by 16% at constant exchange rates to DKK 83.3 billion in the first six months of 2022

29.07.22GlobeNewswireNovo Nordisk achieves primary objectives of ONWARDS 3 and 4 trials with once-weekly insulin icodec demonstrating superior reduction in HbA1c vs insulin degludec in ONWARDS 3

07.06.22GlobeNewswireNovo Nordisk A/S:

03.06.22GlobeNewswireNovo Nordisk achieves primary objectives of ONWARDS 1 and 6 trials with once-weekly insulin icodec demonstrating superior reduction in HbA1c vs insulin glargine U100 in ONWARDS 1

06.05.22GlobeNewswireNovo Nordisk A/S:

02.05.22GlobeNewswireNovo Nordisk – major shareholder announcement

29.04.22GlobeNewswireNovo Nordisk A/S – Total number of voting rights and share capital in Novo Nordisk A/S as of 29 April 2022

29.04.22GlobeNewswireNovo Nordisk's sales increased by 24% in Danish kroner and by 18% at constant exchange rates to DKK 42.0 billion in the first three months of 2022

28.04.22GlobeNewswireOnce-weekly insulin icodec demonstrates superior reduction in HbA1c vs insulin degludec in people with type 2 diabetes in ONWARDS 2 phase 3a trial

27.04.22GlobeNewswireNovo Nordisk A/S – Reduction of the share capital

22.04.22PR NewswireNovo Nordisk Indonesia takes a holistic approach to achieve zero environmental impact

28.03.22GlobeNewswireOzempic® 2.0 mg approved in the US for the treatment of type 2 diabetes

24.03.22GlobeNewswireResolutions from the Annual General Meeting of Novo Nordisk A/S

14.03.22GlobeNewswireNovo Nordisk – major shareholder announcement

04.03.22GlobeNewswireNovo Nordisk – major shareholder announcement

03.03.22GlobeNewswireHighlights to be presented at Novo Nordisk’s Capital Markets Day 2022

28.02.22GlobeNewswireElection of employee representatives to the Board of Directors of Novo Nordisk A/S

21.02.22GlobeNewswireNovo Nordisk – major shareholder announcement

21.02.22GlobeNewswireNotice for the Annual General Meeting of Novo Nordisk A/S

14.02.22GlobeNewswireNovo Nordisk – major shareholder announcement

02.02.22MyDividendsNovo Nordisk hebt die Dividende das 24. Jahr in Folge an

02.02.22GlobeNewswireNovo Nordisk's sales increased by 11% in Danish kroner and by 14% at constant exchange rates to DKK 140.8 billion in 2021

14.01.22GlobeNewswireNovo Nordisk announces settlement of securities lawsuit in Denmark

Novo Nordisk News

Novo Nordisk News: auf dieser Seite finden Sie alle Novo Nordisk News und Nachrichten zur Novo Nordisk Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Novo Nordisk News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Novo Nordisk News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.